News

5th ALIPANC Charity Gala

5th ALIPANC Charity Gala Friday, November 20, at 8:00 p.m. Real Casino de Madrid C. Alcalá, 15, Centro, 28014 Madrid Donation: 200 € per person Join the fight against pancreatic cancer On behalf of the Pancreatic Cancer Research Alliance in Spain (ALIPANC), we would...

Pathology of the Exocrine Pancreas – of men and mice

A 3-day "meet the expert" International Course January 21–23, 2027 CNIO Auditorium, Madrid, Spain This three-day international course will bring together leading experts in pancreatic pathology, cancer biology, translational research, molecular genetics, artificial...

An Integrative RNA Spliceosomic Landscape of Pancreatic Neuroendocrine Tumors Identifies Clinically Relevant Molecular Subgroups

A study led by ALIPANC researchers from the Maimonides Biomedical Research Institute of Cordoba (IMIBIC) and the University of Córdoba (UCO) has provided the first comprehensive RNA spliceosomic landscape of pancreatic neuroendocrine tumors (PanNETs). The results,...

ALIPANC Online Seminar – Dr. Remy Nicolle, October 15, 2026, 3:00 p.m. CET

Speaker: Dr. Remy Nicolley Institution: Pancreatic Cancer Heterogeneity & Translational Genomics Group | Center for Inflammation Research | Paris, France Title:“Morphomolecular Phenotyping of Pancreatic Tumors” Description On October 15 at 3:00 p.m. CET, ALIPANC will...

Development of an epidemiological score for the early detection of pancreatic cancer

An international team—with significant participation from the PADO group at the ICO and IDIBELL, which includes several members of ALIPANC—has developed an epidemiological risk score for the early detection of pancreatic cancer, one of the deadliest cancers due to...

PANTHEIA-SEOM Validates SIRI as a Prognostic Marker in Metastatic Pancreatic Cancer

The multicenter study included 672 patients treated with first-line chemotherapy. A low SIRI score (≤2.3) was associated with longer overall survival (14.0 vs. 9.2 months). It was also associated with longer progression-free survival (5.9 vs. 3.9 months) and a higher...

MNK1, a kinase involved in pancreatic cancer stem cell maintenance

Cancer stem cells (CSCs) are a highly tumorigenic population of pancreatic ductal adenocarcinoma (PDAC) cells that contribute to tumor progression, metastasis, therapy resistance and disease relapse. In this study, Pérez-Ruiz and colleagues investigated apMNKQ2, a DNA...

A new multi-omic atlas of the human pancreas

The ESPACE consortium presents a comprehensive multi-omic atlas of the human pancreas, profiling more than 4 million cells from 57 donors across fetal development, adult homeostasis, and type 2 diabetes. With a particular focus on the exocrine compartment, the study...

Next-generation sequencing analysis of pancreatic cancer samples obtained via endoscopy

A recently published study, led by Elisabeth Pando and Teresa Macarulla, demonstrates that tissue obtained through diagnostic endoscopic biopsy for pancreatic cancer can also be used to perform molecular analyses using next-generation sequencing (NGS). In 74% of...

ALIPANC Online Seminar – Dr. Prof. Dieter – July 21, 3:00 p.m. CET

Speaker: Dr. Prof. Dieter Saur Institution: Technical University of Munich Title:“Decoding the PDAC Ecosystem Through Integrated Computational and Experimental Approaches” Description On July 21 at 3:00 p.m. CET, ALIPANC will hold another session of the ALIPANC...

5th ALIPANC Charity Gala

5th ALIPANC Charity Gala Friday, November 20, at 8:00 p.m. Real Casino de Madrid C. Alcalá, 15, Centro, 28014 Madrid...

read more